Publications by authors named "Christophe Martignier"

Claim this Profile
L
LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures.
Nicolas Gestermann, Damien Saugy, Christophe Martignier, Laure Tillé, Silvia A Fuertes Marraco

Oncoimmunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of cancer cell-intrinsic immune regulation in response to CD8+ T cell attack.
Natalie J Neubert, Laure Tillé, Christophe Martignier, Silvia A Fuertes Marraco, Daniel E Speiser

Methods Enzymol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.
Catherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Christophe Martignier

Cancer Cell· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.
Catherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Christophe Martignier

Cancer Cell· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.
Natalie J Neubert, Martina Schmittnaegel, Natacha Bordry, Sina Nassiri, Noémie Wald, Christophe Martignier

Sci Transl Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis